Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5113-5119

  Tada, Yayoi ^a,c   Asahina, Akihiko ^a   Nakamura, Koichiro ^a   Tomura, Michio ^b   Fujiwara, Hiromi ^b   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; ATOPIC DERMATITIS; BIOASSAY; CONTROLLED STUDY; CORNEA CELL; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034658631     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5113     Document Type: Article

References (41)

1. Katz, S. I., K. Tamaki, and D. H. Sachs. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324.
2. Enk, A.H., and S. I. Katz. 1992. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad Sci. USA 89:1398.
3. Grabbe, S., S. Bruvers, R. L. Gallo, T. L. Knisely, R. Nazareno, and R. D. Granstein. 1991. Tumor antigen presentation by mouse epidermal cells. J. Immunol. 146:3656.
4. Grabbe, S., S. Bruvers, A. M. Lindgren, J. Hosoi, K. C. Tan, and R. D. Granstein. 1992. Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony stimulating factor, tumor necrosis factor α and ultraviolet radiation. J. Leukocyte Biol. 52:209.
5. Aiba, S., and S. I. Katz. 1990. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145:2791.
6. Chang, C.-H., M. Furue, and K. Tamaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur. J. Immunol. 25:394.
7. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz, 1993. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150:3698.
8. Schreiber, S., O. Kilgus, E. Payer, R. Kutil, A. Elbe, C. Mueller, and G. Stingel. 1992. Cytokine pattern of Langerhans cells isolated from mouse epidermal cell cultures. J. Immunol. 150:3525.
9. Heufler, C., G. Topar, F. Koch, B. Trockenbacher, E. Kampgen, N. Romani, and G. Schuler. 1992. Cytokine gene expression in mouse epidermal cell suspensions: interleukin 1β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells hut differently regulated in culture. J. Exp. Med. 176:1221.
10. Kang, K., M. Kubin, K. D. Cooper, S. R. Lessin, G. Trinchieri, and A. H. Rook. 1996. IL-12 synthesis by human Langerhans cells. J. Immunol. 156:1402.
11. + T cells. J. Immunol. 154:5071.
12. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste-Amezaga, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al. 1992. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
13. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181:537.
14. Schwarz, A., S. Grabbe, H. Riemann, Y. Aragane, M. Simon, S. Manon, S. Andrade, T. A. Luger, A Zlotnik, and T. Schwarz. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:211.
15. Grewe, M., C. A. F. M. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A. G. Langeveld-Wildschut, T. Ruzicka, and J. Krutmann. 1998. A role of Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 19:359.
16. Flohe, S. B., C. Bauer, S. Flohe, and H. Moll. 1998. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J Immunol 28:3800.
17. Stebut, E. V., Y. Belkaid, T. Jakob, D. L. Sacks, and M. C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from mouse skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188: 1547.
18. Salgado, C. G., K. Nakamura, M. Sugaya, Y. Tada, A. Asahina, Y. Koyama, S. Irie, and K. Tamaki. 1999. Functional CD40 ligand is expressed on epidermal Langerhans cells. J. Leukocyte Biol. 66:281.
19. Du, C., and S. Sriram. 1998. Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-β in ANA-1 cells. J. Leukocyte Biol. 64:92.
20. Witmer-pack, M.D., W. Oliver, J. Valinsky, G. Schuler, and R. M. Steinman. 1987. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured mouse epidermal Langerhans cells. J. Exp. Med. 166:1484.
21. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526.
22. Takeuchi, M., P. Alard, and J. W. Streilein. 1998. TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1589.
23. Maruo, S., H.-J. Ahn, W.-G. Yu, M. Tomura, M. Wysocka, N. Yamamoto, M. Kobayashi, T. Hamaoka, G. Trinchieri, and H. Fujiwara. 1997. Establishment of an IL-12-responsive T cell clone: its characterization and utilization in the quantitation of IL-12 activity. J. Leukocyte Biol. 61:346.
24. Salgado, C. G., K. Nakamura, M. Sugaya, Y. Tada, A. Asahina, S. Fukuda, Y. Koyama, S. Irie, and K. Tamaki. 1999. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1 and B7-2 expression on purified epidermal Langerhans cells. J. Invest. Dermatol. 113:1021.
25. Muller, G., J. Saloga, T. Germann, I. Bellinghausen, M. Mohamadzadeh, J. Knop, and A. H. Enk. 1994. Identification and induction of human keratinocyte-derived IL-12. J. Clin. Invest. 94:1799.
26. Dinarello, C. A., and S. M. Wolff. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328:106.
27. Kupper, T. S., F. Lee, N. Birchall, S. Clark, and S. Dower. 1988. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte/macrophage colony-stimulating factor mRNA and protein. J. Clin. Invest. 82:1787.
28. Pastore, S., E. Fanales-Belasio, C. Albanesi, L. M. Chinni, A. Giannetti, and G. Girolomoni. 1997. Granulocyte/macrophage colony-stimulating factor is over-produced by keralinocyte in atopic dermatitis. J. Clin. Invest. 12:3009.
29. Snijders, A., C. M. U. Hilkens, T. C. van der Pouw Kraan, M. Engel, L. Aarden, and M. L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulaled human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207.
30. + dendritic epidermal cells: ontogenetic variation and its role in migration. Adv. Exp. Med. Biol. 378:117.
31. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by mouse dendritic cells: upregulalion via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
32. Cella, M., D. Scheidegger, K. P-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
33. Snijders, A., P. Kalinski, C. M. U. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593.
34. Labeur, M. S., B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:168.
35. + subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587.
36. Wood, L. C., P. M. Elias, C. Calhoun, J. C. Tsai, C. Grunfeld, and K. R. Feingold. 1996. Barrier disruption stimulates interleukin 1α expression and release from a pre-formed pool in mouse epidermis. J. Invest. Dermatol. 106:397.
37. Wood, L. C., S. M. Jackson, P. M. Elias, C. Grunfeld, and K. R. Feingold. 1992. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 90:482.
38. Nickoloff, B. J., and Y. Naidu. 1994. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 30:535.
39. Kalinski, P., J. H. N. Schuitemaker, C. M. U. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and so bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162:3231.
40. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161:2804.
41. Rissoan M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. W. Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.